生命科学资讯

Rethinking heart attacks as nervous system gone haywire sparks potential new drug targets

TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio

'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership

United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial

From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot

Lisata reclaims China rights to solid tumor candidate ahead of acquisition

After patient death, FDA lifts hold on 1 of 2 late-stage trials testing Intellia’s CRISPR therapy

Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance

Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial

European investment firm Gimv calls it quits on new life science financing

New rules, higher stakes: Biopharma plays the long game in 2026

Feds charge former Zynex execs in massive medtech billing fraud case

Guardant Health gets FDA nod to expand use of blood test for colon cancer

AstraZeneca keeps UK research site on pause, but options open

Fortitude has faith molecular glue degraders can overcome ADC resistance

'Things are looking up': British biotechs consider going public after yearslong IPO drought

Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials

Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings

Chutes & Ladders—BMS snags top neuro researcher from Eisai

J. Craig Venter launches genomics startup designed to boost diagnostic insights